Table Of Contents

1. Market Context & Strategic Relevance

 1.1 Opening Context (Why the market matters)

 1.1.1 Why This Market Is Gaining Strategic Attention

     1.1.2 Business Decisions This Report Supports

 1.2 Scope

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Type

  2.3.2 Market Size By Clinical Practice

  2.3.3 Market Size By End Use

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Sensor & AI Technology Providers

3.4.2 Digital Biomarker Platform Developers

3.4.3 Distribution & Cloud Service Providers

3.4.4 Healthcare Providers & End Users

 3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting

 4.1 Market Adoption & Usage Trends

4.1.1 Digital Neuro Biomarker Adoption by Device Type

4.1.2 Clinical Practice Utilisation Analysis

4.1.3 Healthcare Provider Adoption Trends

4.1.4 Pharmaceutical & Biotechnology Industry Utilisation

4.1.5 Remote Neurological Monitoring Trends

4.2 Technology & Innovation Insights

4.2.1 AI-Based Neurological Assessment Advancements

4.2.2 Wearable & Sensor Technology Developments

4.2.3 Mobile Health Application Innovation Trends

4.2.4 Digital Biomarker Validation & Clinical Evidence

4.2.5 Regulatory & Digital Health Approval Landscape

4.3 Commercial & Industry Intelligence

4.3.1 Competitive Benchmarking of Leading Companies

4.3.2 Investment & Funding Trends

4.3.3 Strategic Partnerships & Acquisition Activity

4.3.4 Healthcare IT Integration Trends

4.3.5 Research & Development Landscape

4.4 Future Outlook & Emerging Opportunities

4.4.1 Expansion of AI-Driven Neurological Diagnostics

4.4.2 Growth of Remote Patient Monitoring Solutions

4.4.3 Opportunities in Clinical Trial Digitalisation

4.4.4 Future Roadmap for Digital Neuro Biomarker Adoption

5. Digital Neuro Biomarkers Market Segmental Analysis & Forecast, By Type, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 Wearables

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 Mobile Applications

 5.4 Sensors

6. Digital Neuro Biomarkers Market Segmental Analysis & Forecast, By Clinical Practice, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Monitoring, ,

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 Diagnostic

 6.4 Predictive and Prognostic

7. Digital Neuro Biomarkers Market Segmental Analysis & Forecast, By End Use, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Healthcare Providers

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Pharmaceutical and Biotechnology Companies

8. Digital Neuro Biomarkers Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

8.1 Introduction

8.2 North America

 8.2.1 Key Trends

 8.2.2 Digital Neuro Biomarkers Market Size & Forecast, By Type, 2022–2035

 8.2.3 Digital Neuro Biomarkers Market Size & Forecast, By Clinical Practice, 2022–2035

 8.2.4 Digital Neuro Biomarkers Market Size & Forecast, By End Use, 2022–2035

 8.2.5 Digital Neuro Biomarkers Market Size & Forecast, By Country, 2022–2035

  8.2.5.1 USA

  8.2.5.2 Canada

8.3 Europe

 8.3.1 Key Trends

 8.3.2 Digital Neuro Biomarkers Market Size & Forecast, By Type, 2022–2035

 8.3.3 Digital Neuro Biomarkers Market Size & Forecast, By Clinical Practice, 2022–2035

 8.3.4 Digital Neuro Biomarkers Market Size & Forecast, By End Use, 2022–2035

 8.3.5 Digital Neuro Biomarkers Market Size & Forecast, By Country, 2022–2035

  8.3.5.1 Germany

  8.3.5.2 UK

  8.3.5.3 France

  8.3.5.4 Italy

  8.3.5.5 Spain

  8.3.5.6 Russia

  8.3.5.7 Poland

  8.3.5.8 Rest of Europe

8.4 Asia-Pacific

 8.4.1 Key Trends

 8.4.2 Digital Neuro Biomarkers Market Size & Forecast, By Type, 2022–2035

 8.4.3 Digital Neuro Biomarkers Market Size & Forecast, By Clinical Practice, 2022–2035

 8.4.4 Digital Neuro Biomarkers Market Size & Forecast, By End Use, 2022–2035

 8.4.5 Digital Neuro Biomarkers Market Size & Forecast, By Country, 2022–2035

  8.4.5.1 China

  8.4.5.2 India

  8.4.5.3 Japan

  8.4.5.4 South Korea

  8.4.5.5 Australia

  8.4.5.6 ASEAN Countries

  8.4.5.7 Rest of Asia-Pacific

8.5 Latin America

 8.5.1 Key Trends

 8.5.2 Digital Neuro Biomarkers Market Size & Forecast, By Type, 2022–2035

 8.5.3 Digital Neuro Biomarkers Market Size & Forecast, By Clinical Practice, 2022–2035

 8.5.4 Digital Neuro Biomarkers Market Size & Forecast, By End Use, 2022–2035

 8.5.5 Digital Neuro Biomarkers Market Size & Forecast, By Country, 2022–2035

  8.5.5.1 Brazil

  8.5.5.2 Argentina

  8.5.5.3 Mexico

  8.5.5.4 Colombia

  8.5.5.5 Rest of Latin America

8.6 Middle East & Africa

 8.6.1 Key Trends

 8.6.2 Digital Neuro Biomarkers Market Size & Forecast, By Type, 2022–2035

 8.6.3 Digital Neuro Biomarkers Market Size & Forecast, By Clinical Practice, 2022–2035

 8.6.4 Digital Neuro Biomarkers Market Size & Forecast, By End Use, 2022–2035

 8.6.5 Digital Neuro Biomarkers Market Size & Forecast, By Country, 2022–2035

  8.6.5.1 UAE

  8.6.5.2 Saudi Arabia

  8.6.5.3 Qatar

  8.6.5.4 South Africa

  8.6.5.5 Rest of Middle East & Africa

9. Competitive Landscape

 9.1 Key Players' Positioning

 9.2 Competitive Developments

  9.2.1 Key Strategies Adopted (%), By Key Players, 2025

  9.2.2 Year-Wise Strategies & Development, 2022–2025

  9.2.3 Number Of Strategies Adopted By Key Players, 2025

 9.3 Market Share Analysis, 2025

 9.4 Type/Service & Clinical Practice Benchmarking

  9.4.1 Type/Service Specifications & Features By Key Players

  9.4.2 Type/Service Heatmap By Key Players

  9.4.3 Clinical Practice Heatmap By Key Players

 9.5 Industry Start-Up & Innovation Landscape

9.6 Key Company Profiles

 9.6.1 Altoida Inc.

  9.6.1.1 Company Overview & Snapshot

  9.6.1.2 Type/Service Portfolio

  9.6.1.3 Key Company Financials

  9.6.1.4 SWOT Analysis

 9.6.2 Koneksa Health

9.6.3 Biogen Inc.

9.6.4 F. Hoffmann-La Roche Ltd.

9.6.5 NeuraMetrix, Inc.

9.6.6 Merck KGaA

9.6.7 Linus Health, Inc.

9.6.8 Neurotrack Technologies, Inc.

9.6.9 Huma Therapeutics Ltd.

9.6.10 NeuraLight, Ltd.

9.6.11 QIAGEN N.V.

9.6.12 ADx NeuroSciences NV

9.6.13 Thermo Fisher Scientific Inc.

9.6.14 Cognito Therapeutics, Inc.

9.6.15 Click Therapeutics, Inc.

9.6.16 Akili Interactive Labs, Inc.

9.6.17 Sonde Health, Inc.

9.6.18 Winterlight Labs Inc.

9.6.19 Emerald Innovations, Inc.

9.6.20 Rune Labs, Inc.

10. Analyst Recommendations

 10.1 SNS Insider Opportunity Map

 10.2 Industry Low-Hanging Fruit Assessment

 10.3 Market Entry & Growth Strategy

 10.4 Analyst Viewpoint & Suggestions On Market Growth

11. Assumptions

12. Disclaimer

13. Appendix

 13.1 List Of Tables

 13.2 List Of Figures